ClinicalTrials.gov
ClinicalTrials.gov Menu

Chronic Hand Eczema - Self-management and Prognosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01482663
Recruitment Status : Completed
First Posted : November 30, 2011
Last Update Posted : December 3, 2014
Sponsor:
Collaborator:
TrygFonden, Denmark
Information provided by (Responsible Party):
Annette Mollerup, University Hospital, Gentofte, Copenhagen

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Hand eczema is a common disease which often gives a chronic course thus affecting many functions in daily life. The body of evidence related to self-management of chronic hand eczema is poor. Better methods to support self-management of patients with chronic hand eczema may potentially improve the prognosis of a disease which is both a tremendous burden to the individual and to the society. The purpose of this trial is to evaluate the effect of a newly designed guidance programme offering individual counselling compared to conventional information with written information sheets.

Condition or disease Intervention/treatment Phase
Chronic Hand Eczema Chronic Hand Dermatitis Behavioral: Healthy Skin Clinic Not Applicable

Detailed Description:

Detailed description of the trial and the intervention can be found in the publication:

Mollerup A, Veien NK, Johansen JD. Chronic hand eczema--self-management and prognosis: a study protocol for a randomised clinical trial'. BMC Dermatol. 2012 Jun 12;12:6. doi: 10.1186/1471-5945-12-6.

PMID: 22691871 [PubMed - indexed for MEDLINE] Free PMC Article


Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 306 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Chronic Hand Eczema - Self-management and Prognosis
Study Start Date : May 2011
Actual Primary Completion Date : November 2012
Actual Study Completion Date : December 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Eczema

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
No Intervention: Chronic hand eczema patients
Written information sheets and a 14-minutes DVD about hand eczema handed out by the dermatologist
Experimental: Behavioral: Healthy Skin Clinic
1-2 counselling sessions with a nurse, tailored according to individual risks and resources and user access to a website comprising a self-monitoring log, a patients' forum and the possibility of communication with the intervention team of nurses
 Behavioral: Healthy Skin Clinic

The intervention is founded upon three concurrent elements. Firstly, a SKIN-profile generated by data from a baseline questionnaire (S=Susceptibility, K=Competencies, I=Individual characteristics, N=Necessary precautions).

Secondly, a patient self-management book which includes a patient's log and is offered in both an online and a physical form. Also support to self-management is offered through possible asynchronous communication and networking.

Finally, a counselling consultation with a nurse, trained within dermatology.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Hand Eczema Severity Index (HECSI) [ Time Frame: 6 months ]
    Objective assessment of disease severity, measured by HECSI-score at time = 6 months versus HECSI-score at time = 0.


Secondary Outcome Measures :
  1. Dermatology Life Quality Index (DLQI) [ Time Frame: 6 months ]
    DLQI measured by questionnaire at time = 6 months versus DLQI measured by questionnaire at time = 0.

  2. Overall burden of disease (VAS) [ Time Frame: 6 months ]
    VAS measured by questionnaire at time = 6 months versus VAS measured by questionnaire at time = 0.

  3. Danish version of The Medication Adherence Report Scale (DMARS-4) [ Time Frame: 6 months ]
    DMARS-4 measured by questionnaire at time = 6 months versus DMARS-4 measured by questionnaire at time = 0 months.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients clinically diagnosed with hand eczema at the first medical consultation at the outpatient ward, Copenhagen University Hospital Gentofte or at a private dermatologic practise in Aalborg, Denmark
  • Patients who have given a signed informed consent to participate

Exclusion Criteria:

  • Patients who cannot reply to a questionnaire in Danish
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01482663


Locations
Denmark
Dermatologic practise, Vesterbro 99
Aalborg, Denmark, 9000
Department of Dermato-Allergology, Copenhagen University Hospital Gentofte
Hellerup, Denmark, 2900
Sponsors and Collaborators
University Hospital, Gentofte, Copenhagen
TrygFonden, Denmark
Investigators
Principal Investigator: Annette Mollerup, MScHealth Copenhagen University Hospital, Gentofte
Study Director: Jeanne D Johansen, Prof, DMSc Copenhagen University Hospital, Gentofte
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications of Results:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Annette Mollerup, MScHealth, PhD-student, University Hospital, Gentofte, Copenhagen
ClinicalTrials.gov Identifier: NCT01482663     History of Changes
Other Study ID Numbers: CHE-2011-Geh
First Posted: November 30, 2011    Key Record Dates
Last Update Posted: December 3, 2014
Last Verified: December 2014

Keywords provided by Annette Mollerup, University Hospital, Gentofte, Copenhagen:
Hand eczema
Hand dermatitis
Chronic hand eczema
Chronic hand dermatitis
 Contact dermatitis
Skin disease
Self-management

Additional relevant MeSH terms:
Dermatitis
Eczema
Skin Diseases
Skin Diseases, Eczematous